Noxopharm Ltd (NOX) - Cash Flow Conversion Efficiency

Latest as of December 2025: 2.404x

Based on the latest financial reports, Noxopharm Ltd (NOX) has a cash flow conversion efficiency ratio of 2.404x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-2.71 Million ≈ $-1.92 Million USD) by net assets (AU$-1.13 Million ≈ $-797.75K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see NOX market cap overview for the company's overall valuation and market capitalisation.

Noxopharm Ltd - Cash Flow Conversion Efficiency Trend (2016–2025)

This chart illustrates how Noxopharm Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Noxopharm Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Noxopharm Ltd ranked by their cash flow conversion efficiency. Explore NOX cash flow quality score to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Breedon Group PLC LSE:BREE	0.010x
Clean & Science co. Ltd KQ:045520	0.147x
Horseshoe Metals Ltd AU:HOR	0.151x
LEXINGTO GOLD NEW DL-003 F:XX40	N/A
Orissa Bengal Carrier Limited NSE:OBCL	0.015x
Purefun Group AB ST:PURE	0.088x
Wizz Air Holdings PLC LSE:WIZZ	0.897x
Schroder Asia Pacific Fund LSE:SDP	0.001x

Annual Cash Flow Conversion Efficiency for Noxopharm Ltd (2016–2025)

The table below shows the annual cash flow conversion efficiency of Noxopharm Ltd from 2016 to 2025. View Noxopharm Ltd (NOX) share price today for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-06-30	AU$689.96K ≈ $488.19K	AU$-5.82 Million ≈ $-4.12 Million	-8.442x	-6679.01%
2024-06-30	AU$5.50 Million ≈ $3.89 Million	AU$-684.31K ≈ $-484.19K	-0.125x	+89.68%
2023-06-30	AU$9.07 Million ≈ $6.42 Million	AU$-10.95 Million ≈ $-7.75 Million	-1.206x	-111.87%
2022-06-30	AU$24.12 Million ≈ $17.06 Million	AU$-13.73 Million ≈ $-9.72 Million	-0.569x	-162.35%
2021-06-30	AU$40.78 Million ≈ $28.85 Million	AU$-8.85 Million ≈ $-6.26 Million	-0.217x	+74.91%
2020-06-30	AU$12.87 Million ≈ $9.11 Million	AU$-11.14 Million ≈ $-7.88 Million	-0.865x	-112.84%
2019-06-30	AU$-1.45 Million ≈ $-1.03 Million	AU$-9.78 Million ≈ $-6.92 Million	6.740x	+853.61%
2018-06-30	AU$10.15 Million ≈ $7.18 Million	AU$-9.08 Million ≈ $-6.42 Million	-0.894x	+24.37%
2017-06-30	AU$2.47 Million ≈ $1.75 Million	AU$-2.92 Million ≈ $-2.06 Million	-1.183x	-1179.11%
2016-06-30	AU$5.95 Million ≈ $4.21 Million	AU$-549.72K ≈ $-388.96K	-0.092x	--

About Noxopharm Ltd

AU:NOX Australia Biotechnology

Market Cap

$13.26 Million

AU$18.74 Million AUD

Market Cap Rank

#26431 Global

#1202 in Australia

Share Price

AU$0.06

Change (1 day)

-1.61%

52-Week Range

AU$0.06 - AU$0.11

All Time High

AU$1.58